9104
|
|
|
- あまめ あさぶき
- 9 years ago
- Views:
Transcription
1
2 01
3 To Our Shareholders 02
4 03 Consolidated Financial Statements 12,000 8,878 9,039 9,102 9,972 11,300 8,000 5,636 4, /3 2002/3 2003/3 2004/3 2004/9 2,000 1,500 1,600 1, /3 2002/3 2003/3 2004/3 2004/9 1, / / /3 2004/3 2004/9
5 04 Consolidated Financial Statements 0 300, , , , /3 166, /3 164, /3 221, /3 255, /
6 05 Segment Information 1, ,
7 Non-Consolidated Financial Statements 06
8 07 Strategy Report by Division 1 2 3
9 08 4 5
10 09 Special Edition
11 Topics / Board of Directors, Corporate Auditors and Executive Officers 10 T O P I IC S
12
ozu_no98_H.qxd (Page h1)
To Our Shareholders CONTENTS 1 2 3 4 56 78 911 112 13 14 TM 1 2 Group Corporate Information Segment Information 3 4 Topics Topics1 Topics2 Topics3 5 6 8 Special Contents 7 Financial Statements [Consolidated]
株式会社幸楽苑
35th Business Report http://www.kourakuen.co.jp/ To Our Shareholders Management Report CONTENTS 1 2 3 6 7 8 9 11 14 15 16 17 1 2 Management Strategy 3 4 5 6 Management Strategy Commentary Information 7
Q A Q A 1
IHI Report Q A Q A 1 Q A Q A To Our Shareholders 2 706 803 42 9 1,030 790 66 17 1,894 1,716 55 103 3 Business Review by Segment 1,350 57 45 1,310 704 34 16 755 103 31 16 41 763 16 10 554 4 Performance
Otsuka-people creating new products for better health worldwide Contents 02 03 07 08 11 13 15 16 17 01
3 Otsuka-people creating new products for better health worldwide Otsuka-people creating new products for better health worldwide Contents 02 03 07 08 11 13 15 16 17 01 To Our Shareholders Otsuka-people
untitled
1 Report 3 4 8 10 14 16 Topics 18 18 19 19 20 20 21 21 22 23 Information 25 25 2013.9 No.80 1 2 2013.9 No.80 Report 2013.9 No.80 3 4 2013.9 No.80 2013.9 No.80 5 6 2013.9 No.80 2013.9 No.80 7 8 2013.9 No.80
Contents FY2011 Highlight Financial Data Business Outline Of ZOZOTOWN To Overseas Customers Business Outline Of Affiliated Companies About Us Appendix : Notice of the 14th Annual General Meeting of
Annual 2002 Report Financial Highlights 2002 2001 2000 2002 2,581,399 2,750,418 2,680,611 19,372 28,402 26,494 11,173 213 4.17 3.89 1.64 $ 0.031 907,150 979,695 889,220 6,807 4,030,596 4,232,011 4,172,459
untitled
financial report - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - -
ゼリア新薬工業株式会社
C O N T E N T S TOP INTERVIEW Q A Q A Q A 10.9 22.9 66.2 ZERIA Pharmaceutical Co.,Ltd. 1 TOP INTERVIEW Q A 2 ZERIA Pharmaceutical Co.,Ltd. ZERIA Pharmaceutical Co.,Ltd. 3 Q A Q A Q A Q A R&D III II I II
株式会社フジテレビジョン
67 194119930 Cover 2 Top Message 3 Top Interview 6 Topics 7 Fuji TV Outline 11 Consolidated Financial Statements 13 Non-Consolidated Financial Statements 14 Corporate Social Responsibility Report 15 Group/Network
maiji2007_cover_j_0907
27 CORPORATE PHILOSOPHY THE MEIJI DAIRIES GROUP CONTRIBUTES TO A HEALTHY AND HAPPY DAILY LIFE FOR OUR CUSTOMERS BY OFFERING NEW LEVELS OF VALUE IN FOOD. CONTENTS 2 4 6 1 1 11 12 13 14 16 18 19 2 22 23
untitled
27.4.1 s 28.3.31 31 8515 Vol.24 June 28 Top Message 283 1 16 4 17 5 Topics 18 CSR 7 19 1 2 12 21 21 4,574,99 321,63274 1 3 Top Message 2 4,112 33 317 2825 7 64%5% ROA1.5% 5, 1, 15, 2, 25, 3, 25,225 25/3
ペトロルブインターナショナル株式会社
Petrolub Report 1 2 New Products BP X-COOL for Import Cars BP X-COOL for Sports BP X-COOL for Racing 3 4 Sales Promotion 5 6 Financial Statements 5 039 578 5 191 730 2 352 981 2 949 291 1 746 153 1 284
Financial Highlights 15, 3, 3, 13, ,152 2,524 2,611 12, 2,5 2,5 17,425 19,792 2,15 1,424 2, 1,861 2, 9, 1,5 1,5 6, 1,71 1, , , 5
lnterim Business Report 第 64 期中間報告書 21 年 4 月 1 日から 21 年 9 月 3 日まで 証券コード :7537 Financial Highlights 15, 3, 3, 13,165 124,152 2,524 2,611 12, 2,5 2,5 17,425 19,792 2,15 1,424 2, 1,861 2, 9, 1,5 1,5 6, 1,71
FINANCIAL FACT BOOK 2002 CONTENTS CONTENTS Sales Data Net Sales Sales Composition Sales by Region Profit Data Cost Composition & Operating Income/Net
FINANCIAL FACT BOOK 2002 FINANCIAL FACT BOOK 2002 CONTENTS CONTENTS Sales Data Net Sales Sales Composition Sales by Region Profit Data Cost Composition & Operating Income/Net Sales Gross Profit Margin
